The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 24, 2019

Filed:

Oct. 01, 2015
Applicant:

Nitto Denko Corporation, Osaka, JP;

Inventors:

Takuya Shishido, Osaka, JP;

Daisuke Asari, Osaka, JP;

Kyohei Matsushita, Osaka, JP;

Katsuyuki Okubo, Osaka, JP;

Mitsuhiko Hori, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/00 (2006.01); A61K 39/02 (2006.01); A61K 39/12 (2006.01); A61K 9/70 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/70 (2013.01); A61K 39/00 (2013.01); A61K 39/0011 (2013.01); A61K 39/02 (2013.01); A61K 39/12 (2013.01); A61K 2039/54 (2013.01); A61K 2039/55572 (2013.01); A61K 2039/575 (2013.01); A61K 2039/70 (2013.01);
Abstract

The present invention provides a vaccine pharmaceutical composition for transdermal administration which is safe, usable as a prophylactic or therapeutic agent for cancer or infectious diseases, and capable of safely and effectively inducing a systemic immune response. It can be administered to a human or animal skin, the vaccine pharmaceutical composition including: a lipopolysaccharide or its salt, derived from at least one gram-negative bacterium such as, and, as an immunostimulant; and at least one antigen, the vaccine pharmaceutical composition having a mass ratio between the immunostimulant and the antigen, the total mass of the immunostimulant/the total mass of the antigen, of 0.002 to 500.


Find Patent Forward Citations

Loading…